Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression

Published:2022-01 Issue: Volume:95 Page:153867
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Rong Weihao,Wan Nanyan,Zheng Xian,Shi Gaofeng,Jiang Cuihua,Pan Ke,Gao Meng,Yin Zhiqi,Gao Ze-Jun,Zhang Jian

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference49 articles.

1. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer;Bouillez;Oncogene,2017

2. Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance;Chen;Chin. J. Cancer,2009

3. Sinomenine inhibits B7-H1 and B7-DC expression on human renal tubular epithelial cells;Chen;Int. Immunopharmacol.,2005

4. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription;Chen;Mol. Immunol.,2006

5. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells;Coombs;Cancer Lett.,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chrysin Enhances Anti‐Cancer Activity of Jurkat T Cell and NK‐92 Cells Against Human Breast Cancer Cell Lines;Chemistry & Biodiversity;2024-09-04

2. Oncolytic Peptide‐Nanoplatform Drives Oncoimmune Response and Reverses Adenosine‐Induced Immunosuppressive Tumor Microenvironment;Advanced Healthcare Materials;2024-07-09

3. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

4. Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor;Frontiers in Immunology;2024-01-17

5. Progress in small-molecule inhibitors targeting PD-L1;RSC Medicinal Chemistry;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3